Human Investing’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $603K | Sell |
15,895
-26
| -0.2% | -$1.2K | 0.08% | 59 |
|
|
2026
Q2 | $763K | Sell |
15,921
-481
| -3% | -$20.7K | 0.1% | 52 |
|
|
2026
Q1 | $603K | Sell |
16,402
-1,389
| -8% | -$65.8K | 0.09% | 58 |
|
|
2025
Q4 | $905K | Sell |
17,791
-1,019
| -5% | -$52.1K | 0.13% | 46 |
|
|
2025
Q3 | $1.04M | Sell |
18,810
-1,712
| -8% | -$100K | 0.15% | 37 |
|
|
2025
Q2 | $1.42M | Sell |
20,522
-1,376
| -6% | -$93.6K | 0.22% | 33 |
|
|
2025
Q1 | $1.52M | Sell |
21,898
-108
| -0.5% | -$8.92K | 0.27% | 32 |
|
|
2024
Q4 | $1.89M | Sell |
22,006
-867
| -4% | -$93.8K | 0.34% | 28 |
|
|
2024
Q3 | $2.72M | Sell |
22,873
-417
| -2% | -$55.6K | 0.49% | 26 |
|
|
2024
Q2 | $3.32M | Hold |
23,290
| – | – | 0.65% | 22 |
|
|
2024
Q1 | $2.99M | Sell |
23,290
-206
| -0.9% | -$24.5K | 0.6% | 26 |
|
|
2023
Q4 | $2.43M | Sell |
23,496
-1,702
| -7% | -$168K | 0.52% | 26 |
|
|
2023
Q3 | $2.29M | Sell |
25,198
-334
| -1% | -$29.4K | 0.53% | 25 |
|
|
2023
Q2 | $2.07M | Sell |
25,532
-732
| -3% | -$59.8K | 0.47% | 27 |
|
|
2023
Q1 | $2.09M | Sell |
26,264
-1,360
| -5% | -$96.4K | 0.51% | 26 |
|
|
2022
Q4 | $1.87M | Sell |
27,624
-3,500
| -11% | -$205K | 0.48% | 28 |
|
|
2022
Q3 | $1.55M | Sell |
31,124
-408
| -1% | -$21.9K | 0.4% | 36 |
|
|
2022
Q2 | $1.76M | Sell |
31,532
-376
| -1% | -$20.9K | 0.42% | 35 |
|
|
2022
Q1 | $1.77M | Sell |
31,908
-12,500
| -28% | -$642K | 0.39% | 37 |
|
|
2021
Q4 | $2.49M | Sell |
44,408
-11,660
| -21% | -$632K | 0.59% | 26 |
|
|
2021
Q3 | $2.69M | Sell |
56,068
-3,308
| -6% | -$160K | 0.63% | 24 |
|
|
2021
Q2 | $2.49M | Sell |
59,376
-642
| -1% | -$24.9K | 0.61% | 27 |
|
|
2021
Q1 | $2.02M | Sell |
60,018
-6,254
| -9% | -$223K | 0.52% | 31 |
|
|
2020
Q4 | $2.32M | Sell |
66,272
-14,942
| -18% | -$516K | 0.66% | 25 |
|
|
2020
Q3 | $2.82M | Sell |
81,214
-7,342
| -8% | -$245K | 0.93% | 19 |
|
|
2020
Q2 | $2.9M | Sell |
88,556
-24,702
| -22% | -$788K | 1.02% | 15 |
|
|
2020
Q1 | $3.41M | Sell |
113,258
-11,704
| -9% | -$348K | 1.48% | 12 |
|
|
2019
Q4 | $3.62M | Buy |
124,962
+36
| +0% | +$997 | 1.18% | 13 |
|
|
2019
Q3 | $3.23M | Sell |
124,926
-2,004
| -2% | -$50.7K | 1.14% | 14 |
|
|
2019
Q2 | $3.24M | Sell |
126,930
-5,964
| -4% | -$147K | 1.18% | 15 |
|
|
2019
Q1 | $3.48M | Sell |
132,894
-3,456
| -3% | -$84.9K | 1.3% | 12 |
|
|
2018
Q4 | $3.14M | Buy |
+136,350
| New | +$3.03M | 1.31% | 10 |
|
Other funds holding NVO
Human Investing's NVO Position: Q3 2026 in Review
Human Investing reduced its Novo Nordisk (NVO) stake by 0.16% in Q3 2026, selling an estimated $1.2K and leaving 15,895 shares worth $603K. The position accounts for 0.08% of the portfolio, ranked #59.
Human Investing first reported a position in NVO in Q4 2018 and has held it in 32 quarters since. The position peaked at $3.62M in Q4 2019. 1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Human Investing held 15,895 shares of Novo Nordisk worth $603K as of Q3 2026.
- Human Investing sold 26 Novo Nordisk shares in Q3 2026, an estimated $1.2K.
- Novo Nordisk made up 0.08% of Human Investing's portfolio in Q3 2026, its #59 holding.
- Human Investing first reported a position in Novo Nordisk in Q4 2018 and has held it in 32 quarters since.
- Human Investing's Novo Nordisk position peaked at $3.62M in Q4 2019.
- 1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Human Investing's 13F filing for Q3 2026, filed 19 Oct 2026.